Skip to Main Content
Try STAT+ TODAY
Trending:
The Obesity Revolution
Biotech
Health
STAT+
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Pharma
STAT+

Week of Feb. 27: What to watch for in biopharma

  • Damian Garde

By Damian Garde Feb. 27, 2017

Reprints
The Week Ahead
Alex Hogan/STAT

Here’s what we’re looking out for this week in the worlds of pharma and biotech:

Deciding the future of the FDA

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Damian Garde

Damian Garde

National Biotech Reporter

Damian Garde covers biotech, is a co-writer of The Readout newsletter, and a co-host of "The Readout LOUD" podcast.

Tags

Pressure is building on pharma and biotech companies to…
Pressure is building on pharma and biotech companies to take climate action
Why we need mandatory labeling of GMO products
Why we need mandatory labeling of GMO products
Pharmalittle: WHO may add obesity drugs to essential medicines…
Pharmalittle: WHO may add obesity drugs to essential medicines list; monkey shortage may delay drug development
Shortage of monkeys for early-stage research jeopardizes timelines for…
Shortage of monkeys for early-stage research jeopardizes timelines for developing some drugs
Pressure is building on pharma and biotech companies to…
Pressure is building on pharma and biotech companies to take climate action
Republicans press Becerra on gender-affirming care, reproductive rights
Republicans press Becerra on gender-affirming care, reproductive rights

Recommended Stories